International Journal of Antimicrobial Agents

Papers
(The median citation count of International Journal of Antimicrobial Agents is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Title Page & Editorial Board85
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page71
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems70
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms60
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen59
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page57
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis53
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr53
Title Page & Editorial Board52
Characterisation of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol51
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings50
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page46
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page45
Heterogeneous Vancomycin Intermediate Staphylococcus aureus infections in tertiary care hospitals in Coastal Karnataka, India45
Mycobacterium species on the cutaneous microbiome of very preterm neonates admitted to the NICU in a tertiary health care hospital43
Emergence of intrinsically resistant Gram-negative bacteria with an environmental primary habitat41
Vaccines against SARS-COV-240
Antimicrobial therapy for carbapenem-resistant gram-negative bacteria40
In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae39
Severe Salmonella enteritidis infection complicated with colonic perforations and abdominal cocoon38
Hospitalization decision model for COVID-19 patients with comorbidities37
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page36
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota34
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page34
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen33
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae33
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria32
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho32
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis32
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis31
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans31
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy30
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure30
The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients29
Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia28
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting28
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo27
Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China26
Antibiotic resistance in Enterobacter hormaechei26
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis26
Resistance profiling and molecular characterization of methicillin-resistant Staphylococcus pseudintermedius isolated from dogs and cats25
How I treat CMV infection in high-risk pediatric patients?25
Extended infusion improves meropenem and piperacillin/tazobactam effectiveness in septic burn patients with normal renal by applying pharmacokinetics-pharmacodynamics approach25
Psychological effects of paramedics by experience of managing COVID-19 patients24
Cross-talk between signal transduction systems and metabolic networks in antibiotic resistance and tolerance24
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases24
Demography and antibiotic susceptibility of emerging Chryseobacterium gleum among hospitalised patients in Malaysia24
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study24
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Re24
Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae24
Global evolutionary dynamics of virulence genes in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae24
In reply to the Letter to the Editor regarding Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: A systematic review and23
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page23
Detection of mcr-1-harbouring Escherichia coli by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors23
Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae22
Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference22
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospect22
Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV22
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam:22
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis22
MRSA surveillance programmes worldwide: moving towards a harmonised international approach21
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection21
Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents21
Individualised amoxicillin-clavulanate dosing recommendations for critically ill children with augmented clearance after cardiac surgery21
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant21
Alterins, a new family of marine antibacterial cyclolipopeptides20
Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis20
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohor20
Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae20
Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap20
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii20
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci20
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-ce19
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients19
Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity19
Machine learning accelerates the discovery of epitope-based dual-bioactive peptides against skin infections19
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance19
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice19
Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections19
Genomic characterization of vancomycin-resistant Enterococcus faecium transmission in hospital by whole genome sequencing18
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy18
Eczematous skin colonization pattern with potential bacterial pathogens in paediatric population at a tertiary care setting, in Sri Lanka18
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel18
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan18
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals18
Study on antibiotic resistance of Staphylococcus aureus isolated in Hue University hospital in 2018 and 201918
PROGRAM-AT-A-GLANCE18
High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy18
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus18
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)18
Antimicrobial susceptibility and co-resistance among Pseudomonas aeruginosa isolates from hospital-acquired respiratory-tract infections: SMART 2017–2019 Malaysia18
Title Page & Editorial Board18
Title Page & Editorial Board18
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans, coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity18
Title Page & Editorial Board18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page17
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study17
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page17
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based17
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools17
Toxoplasma gondii infection or acute retinal necrosis in early stage: A case report17
Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring?17
NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study17
Molecular investigation of an epidemic dissemination of vancomycin-resistant Enterococcus faecium sequence type 80 in Guangdong province, China17
A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa17
Global distribution of blaCMY-42, a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli17
Corrigendum to “Clinical and Economic Evaluation of Blood Culture Whole Process Optimisation in Critically Ill Adult Patients With Positive Blood Cultures” [International Journal of Antimicrobial Agen17
Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia17
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations17
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing17
High diversity of blaNDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital16
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines16
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan16
Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis16
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study16
A case of atypical hemolytic uremic syndrome caused by Escherichia fergusonii mimicking Escherichia coli in an immunocompetent adult15
Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii15
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates15
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study15
Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes.15
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and15
What we learned from COVID-19 vaccination15
Title Page & Editorial Board15
High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria15
Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa15
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page15
Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis15
In-silico identification of novel inhibitors for glutamate racemase (MurI) to decipher the subtle of antimicrobial resistance in Neisseria gonorrhoeae: A virtual screening and molecular dynamics appro15
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis15
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series15
Characteristic of Stenotrophomonas maltophilia antimicrobial profile in Malaysian isolates 2015–202015
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page15
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial14
Ferric chloride induces ferroptosis in Pseudomonas aeruginosa and heals wound infection in a mouse model14
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification14
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker14
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae14
Human tissue distribution of caspofungin14
Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study14
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion14
Rising threat of metallo-β-lactamase-producing Klebsiella oxytoca complex in Taiwan, 2013–202214
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece14
Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration14
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover cli14
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial14
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies14
Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study14
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials13
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI13
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data13
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem13
Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis13
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam13
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals13
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain13
How to combine novel techniques with stewardship: A real-world experience13
BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function13
Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study13
Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy13
Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses13
Pharmacodynamics of ceftriaxone for the treatment of methicillin‐susceptible Staphylococcus aureus: is it a viable treatment option?13
High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus13
Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient13
Optimising culture results of orthopaedic infections using blood culture bottles12
Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan12
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis12
Susceptibility of Southeast Asian Plasmodium falciparum isolates to P21812
Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme12
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future12
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance12
Pro) Piperacillin-tazobactam for ESBL-producing Enterobacterales12
Con) Piperacillin-tazobactam for ESBL-producing Enterobacterales12
Sequential treatment effects on phage–antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii12
Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns12
In Vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing infection after cefiderocol-based treatment12
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus12
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam12
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses12
Genomic characterization of phenotypically carbapenem-resistant Escherichia coli isolates carrying unknown resistance genes in Malaysia12
New options for bloodstream infections caused by colistin‐ or ceftazidime/avibactam‐resistant Klebsiella pneumoniae12
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience12
The dlt operon contributes to the resistance to chlorhexidine in Streptococcus mutans12
Cellular and genetic changes during and after fluconazole exposure in Cryptococcus neoformans12
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections12
Intravenous to oral antibiotics versus intravenous antibiotics: a step-up or a step-down for extended spectrum β-lactamase (ESBL)-producing urinary tract infections without concomitant bacteraemia?12
The antimicrobial activity of innate host-directed therapies: A systematic review12
Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance11
Strategies for quorum sensing inhibition as a tool for controlling Pseudomonas aeruginosa infections11
Clinical and laboratory factors in predicting mortality among SARS-CoV-2 RNA positive patients from a tertiary care center in South Tamilnadu – A retrospective observational study11
Reviewer Thank you List 202111
The epidemiology and clinical spectrum of melioidosis in a tertiary hospital in a north-eastern state of Malaysia: A three-year review11
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity11
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis11
The evolution of carbapenem-resistant Pseudomonas aeruginosa in the COVID-19 era: A global perspective and regional insights11
Molecular typification of Escherichia coli from community-acquired urinary tract infections in Mexico11
Clinical features and outcomes of vancomycin-resistant enterococcal meningitis in neonatal intensive care unit patients: presentation of three cases11
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade11
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page11
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes11
The Trifecta of Diagnostic Stewardship, Antimicrobial Stewardship, and Value Assessment of New Diagnostic Tests11
In vitro activity of WCK 5222 (cefepime/zidebactam) against bioterror pathogen Burkholderia pseudomallei11
Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a ‘One Health’ study11
Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing11
A translational rat model to assess glomerular function changes with vancomycin11
A 22-year Brazilian colistin resistance surveillance on Escherichia coli and Salmonella spp. originating from food-producing animals11
IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study11
Title Page & Editorial Board11
Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltr11
Title Page & Editorial Board11
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial11
Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration11
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Dat11
Trial Sequential Analysis of Intrathecal/Intraventricular Antimicrobial Therapy for Post-Neurosurgical Gram-Negative Bacillary Meningitis or Ventriculitis11
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the O11
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability10
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae10
Pattern and appropriateness of antibiotic prescriptions for upper respiratory tract infections in primary care paediatric patients10
Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics10
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan10
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria10
Pro) Early oral transition for endocarditis10
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-202010
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis10
Anti-Porphyromonas gingivalis nanotherapy for maintaining bacterial homeostasis in periodontitis10
Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis10
Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients10
MtrAB two-component system is crucial for the intrinsic resistance and virulence of Mycobacterium abscessus10
Antimicrobial resistance profiles and molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolates from pigs in South Korea10
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?10
Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance10
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeabilit10
Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin10
Blockade of pan-viral propagation by inhibition of host cell PNPT110
Population pharmacokinetics of nirmatrelvir in Chinese patients with COVID-19: Therapeutic drug monitoring and dosing regimen selection in clinical practice10
Efficacy of adding azithromycin to antibiotic prophylaxis in caesarean delivery: a meta-analysis and systematic review9
Evaluation of deoxythymidine-based cationic amphiphiles as antimicrobial, antibiofilm, and anti-inflammatory agents9
Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis9
Place of COVID-19 transmission in blood transmission: A case report9
Efficacy of teicoplanin for bloodstream infection caused by Enterococcus faecium: a post-hoc analysis of a nationwide surveillance9
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis9
Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid9
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study9
Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance9
Clinical metagenomics for complicated skin and soft tissue infections9
Phage therapy combats pan drug-resistant Acinetobacter baumannii infection safely and efficiently9
A nation-wide multicentric study on community acquired urinary tract infection among children from a developing country9
Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing9
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification9
Systematic review of disulfiram as an antibacterial agent: what is the evidence?9
Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia9
0.062176942825317